RecruitingNCT07371312

Outcomes of Couples After Failed PGD Management: A Single-Center Study at the Paris PGD Center (Antoine Béclère - Necker)


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

900 participants

Start Date

Mar 25, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Preimplantation genetic testing (PGT) is a reproductive genetic technique aimed at preventing the transmission of severe genetic disorders. In France, its use is strictly regulated and reserved for complex medical situations, often associated with challenging reproductive histories and significant psychological burden. Despite scientific advances, success rates in preimplantation genetic testing remain limited, making the care pathway a significant source of uncertainty regarding the future of the parental project.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria4

  • Woman belonging to a couple who initiated at least one ovarian stimulation cycle for IVF (± ICSI) with preimplantation genetic diagnosis (PGD).
  • No further PGD-related procedures (oocyte retrieval or embryo transfer) performed in the center after December 31, 2022.
  • No live-born child resulting from PGD care.
  • Woman who expressed her free and informed non-opposition to participation.

Exclusion Criteria2

  • One or more live-born children resulting from PGD care in the center.
  • PGD involving gamete donation.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Hôpital Antoine Béclère

Clamart, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07371312


Related Trials